Vectura Group Stock Forecast, Price & News

Vectura Group (OTCMKTS:VEGPF) Frequently Asked Questions

Is Vectura Group a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vectura Group in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Vectura Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VEGPF, but not buy additional shares or sell existing shares.
View analyst ratings for Vectura Group or view top-rated stocks.

What stocks does MarketBeat like better than Vectura Group?

Wall Street analysts have given Vectura Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vectura Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Vectura Group?

Vectura Group saw a drop in short interest in September. As of September 30th, there was short interest totaling 11,700 shares, a drop of 19.3% from the September 15th total of 14,500 shares. Based on an average daily trading volume, of 1,200 shares, the short-interest ratio is currently 9.8 days.
View Vectura Group's Short Interest.

How has Vectura Group's stock been impacted by Coronavirus?

Vectura Group's stock was trading at $1.12 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, VEGPF stock has increased by 92.0% and is now trading at $2.15.
View which stocks have been most impacted by COVID-19.

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:

• Will Downie, Chief Executive Officer & Executive Director
• Anthony Fitzpatrick, Executive Vice President-Operations
• Paul Andrew Fry, Chief Financial Officer & Executive Director
• Gonzalo de Miquel, Chief Medical Officer & Executive VP-Development
• Roger Heerman, Executive VP-Commercial & Business Development

Who are some of Vectura Group's key competitors?

Some companies that are related to Vectura Group include 23andMe (ME), I-Mab (IMAB), Alkermes (ALKS), Mawson Infrastructure Group (WIZP), TG Therapeutics (TGTX), Ionis Pharmaceuticals (IONS), Arvinas (ARVN), Karuna Therapeutics (KRTX), Aurinia Pharmaceuticals (AUPH), Schrödinger (SDGR), Cryoport (CYRX), Intra-Cellular Therapies (ITCI), Reata Pharmaceuticals (RETA), Zentalis Pharmaceuticals (ZNTL) and Lyell Immunopharma (LYEL).
View all of VEGPF's competitors.

What is Vectura Group's stock symbol?

Vectura Group trades on the OTCMKTS under the ticker symbol "VEGPF."

How do I buy shares of Vectura Group?

Shares of VEGPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vectura Group's stock price today?

One share of VEGPF stock can currently be purchased for approximately $2.15.

How much money does Vectura Group make?

Vectura Group has a market capitalization of $1.30 billion and generates $244.76 million in revenue each year. The company earns $157.16 million in net income (profit) each year or $0.26 on an earnings per share basis.

How many employees does Vectura Group have?

Vectura Group employs 502 workers across the globe.

What is Vectura Group's official website?

The official website for Vectura Group is www.vectura.com.

Where are Vectura Group's headquarters?

Vectura Group is headquartered at One Prospect West, Wiltshire X0, SN14 6FH.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, Wiltshire X0, SN14 6FH. The company can be reached via phone at 441249667700 or via email at [email protected].